Carecubes

What Carecubes does

Carecubes is a privately held medical device company founded in 2020 by Alex Laskey and Saul Griffith to commercialize the Carecube ISTARI, an FDA 510(k)-cleared mobile negative pressure isolation unit. The technology, originally conceived during the 2014 Ebola outbreak with DARPA funding and refined in collaboration with the University of Nebraska Medical Center's Global Center for Health Security, converts any standard hospital bed into an isolation bed in approximately 10 minutes. The unit maintains negative pressure at or below -2.5 pascals, delivers 15 or more air exchanges per hour through H14 HEPA filtration (99.997% particulate removal at 0.3 micrometers), and exceeds CDC standards for Airborne Infection Isolation Rooms. The Carecube's design philosophy isolates the pathogen rather than the patient, enabling face-to-face care without full PPE and supporting family visitation through protective arm sleeves.

The company sells its hardware primarily through a direct enterprise field sales motion to U.S. hospital systems, healthcare facilities, and government and emergency preparedness agencies. Named customers include Bellevue Hospital (NYC Health+Hospitals), Providence Sacred Heart Medical Center, Cooper University Health Care, Sacramento County Public Health, the Maryland Hospital Association, and the Metro Health & Medical Preparedness Coalition of Minnesota. As of June 2026, Carecubes had deployed units across 47 communities in 15 states, up from 36 communities in 13 states three months earlier. A flagship integration with MobileOp4, announced January 2026, embeds Carecube units inside climate-controlled modular infrastructure to create transportable isolation environments for emergency response and mass-gathering events.

Carecubes is funded through approximately $4 million in non-dilutive government grants (CDC, ASPR, DARPA), a $2.6 million seed round in 2023, and a $6.5 million Series A in March 2026 from strategic healthcare operators and healthcare-focused funds. The company has 7 full-time employees plus part-time staff, with active hiring plans across operations, product delivery, marketing, and sales. In June 2026, Kabir Gulati was appointed CEO, replacing founder Alex Laskey, who transitioned to Executive Chairman. Manufacturing is based in Minnesota with a multi-state supplier footprint. Pricing is quote-based and not publicly disclosed, consistent with enterprise medical-device sales cycles.

Name

Carecubes

Legal name

Carecubes, Inc

Website

https://carecubes.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Carecubes develops the FDA 510(k)-cleared Carecube ISTARI, a mobile negative-pressure isolation unit that converts standard hospital beds into isolation beds in minutes, selling primarily to U.S. hospital systems and government emergency preparedness agencies.

Ownership category

akta.pro rank

Product category

Medical Isolation Equipment

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions) (HLAHANAK)

Keywords

• Medical isolation devices
• Negative pressure isolation
• Infectious disease control
• Hospital isolation equipment
• Pandemic preparedness equipment

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Carecube Hardware Sales: One-time sale of Carecube ISTARI isolation units to hospitals, clinics, and emergency response systems. The product is available for purchase following FDA 510(k) clearance. Manufactured in Minnesota with suppliers in North Carolina, Connecticut, California, and Ohio.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Carecubes manufactures and sells the Carecube ISTARI, an FDA 510(k)-cleared mobile negative pressure isolation unit that converts any standard hospital bed into an isolation bed in approximately 10 minutes. The device isolates pathogens rather than patients, enabling face-to-face bedside care without full PPE. It features H14 HEPA filtration, negative pressure meeting CDC Airborne Infection Isolation Room standards, and protective arm sleeves for compassionate care delivery.

Product overview

Carecubes offers a single core product: the Carecube ISTARI, an FDA 510(k)-cleared mobile isolation unit. The Carecube converts any standard hospital bed into a negative-pressure isolation bed in approximately 10 minutes, isolating pathogens rather than patients to enable safe, compassionate bedside care while reducing PPE use and staffing costs. The company also offers an integrated product configuration in partnership with MobileOp4, combining CareCube isolation units with climate-controlled modular infrastructure for expanded transportable deployment scenarios.

Differentiator

Problem solved

Functional benefit

Brands

• Carecube ISTARI: FDA 510(k)-cleared isolation unit built for rapid deployment in healthcare settings to prevent infectious disease transmission

Products and services

• Carecube ISTARI FDA 510(k)-cleared mobile isolation unit that converts standard hospital beds into negative-pressure isolation beds in as few as 10 minutes. Features H14 HEPA filtration (99.997% particulate removal at 0.3 micrometers), negative pressure of \u2264 -2.5 pascals, 15+ air exchanges per hour meeting CDC Airborne Infection Isolation Room standards, and protective arm sleeves enabling face-to-face care without full PPE. For hospitals, healthcare systems, and emergency preparedness organizations.
• CareCube and MobileOp4 Integrated Solution Combined solution integrating CareCube isolation units inside MobileOp4's climate-controlled modular infrastructure, creating a transportable isolation and operations environment for healthcare, emergency response, and mass-gathering events with rapid deployment and relocation capability.

Quantifiable outcome

• Deploys in as few as 10-15 minutes
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Five partnerships are on record, tiered flagship and core.

• MobileOp4flagshipTechnology or Integration · 15 January 2026Integration partnership enabling CareCube isolation units to be installed inside MobileOp4's climate-controlled modular infrastructure for transportable isolation and operations environments.
• University of Nebraska Medical CentercoreStrategic or Co-development PartnerStrategic partnership for product development and testing. UNMC's Global Center for Health Security conducted early design tests and provided infectious disease expertise. Dr. James Lawler, Dr. Jana Broadhurst, Dr. David Brett-Major and other UNMC experts shaped product development.
• Mike Kaufmann (Cardinal Health)coreStrategic or Co-development PartnerFormer CEO of Cardinal Health. Board member and investor. Brings supply chain and healthcare distribution expertise.
• Andy Stern (SEIU)coreStrategic or Co-development PartnerFormer Chairman of SEIU. Board member bringing healthcare worker advocacy perspective and labor movement expertise.
• Joe GrogancoreStrategic or Co-development PartnerFormer Director of White House Domestic Policy Council. Board member providing healthcare policy expertise and government relations experience.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• STERIS: STERIS is a global leader in infection prevention, sterilization, and surgical solutions serving hospitals and life sciences. It overlaps with Carecubes' infection-control mission but operates at much larger scale across sterilization, disinfectant, and facility-services categories rather than mobile negative-pressure isolation.
• Halma plc: Halma owns healthcare and safety subsidiaries (e.g., Medicom, Amici, BioFit) focused on infection control, patient safety, and environmental monitoring. It is comparable as a diversified safety/healthcare holding with infection-prevention exposure.
• Getinge: Getinge provides infection control, surgical, and ICU solutions to hospitals worldwide, including sterilization and ventilation products. It is comparable as a hospital-facing infection-control medical-device vendor, though Carecubes focuses specifically on mobile negative-pressure isolation rather than fixed infrastructure.
• Becton, Dickinson and Company (BD): BD is a major medical device company with infection-prevention products (needles, syringes, sharps disposal, drapes) sold to hospitals globally. It is comparable as a hospital-channel medical-device incumbent in infection prevention but does not directly compete in mobile isolation chambers.
• Mölnlycke Health Care: Mölnlycke provides wound care, surgical, and infection-prevention solutions (single-use drapes, gowns, antiseptics) to hospitals globally. It is comparable as a hospital infection-prevention incumbent but is centered on disposables rather than reusable isolation hardware.
• Stryker: Stryker is a large medical device company selling hospital beds, stretchers, and surgical equipment to US health systems. It is comparable as a hospital-channel med-device vendor and the indirect source of the standard beds that Carecube retrofits into isolation beds.
• 3M Health Care: 3M Health Care supplies PPE, surgical drapes, and infection-prevention products to hospitals and public health agencies. Its PPE-centric model is the alternative Carecubes is positioned against, making it thematically comparable as a hospital infection-control vendor.
• Ecolab Healthcare: Ecolab's Healthcare division provides infection prevention, surgical instrument cleaning, and bio-decontamination (via Bioquell) for hospitals. It competes for hospital infection-control budgets with a chemicals- and services-led model versus Carecubes' hardware isolation model.
• Owens & Minor (Halyard): Owens & Minor distributes medical/surgical supplies including the legacy Halyard infection-prevention portfolio (gowns, drapes, sterilization wraps). It is comparable as a hospital-channel infection-prevention supplier competing for similar capital budgets.

Emerging players

• Bioquell (Ecolab): Bioquell, now part of Ecolab, provides hydrogen peroxide vapor bio-decontamination for hospital rooms and isolation units. It is comparable as a complementary/sometimes alternative infection-control technology deployed in healthcare and biopharma settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/carecubes

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carecubes